dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:28:34Z
dc.date.available2014-05-27T11:28:34Z
dc.date.created2014-05-27T11:28:34Z
dc.date.issued2013-03-01
dc.identifierFood and Chemical Toxicology, v. 53, p. 153-159.
dc.identifier0278-6915
dc.identifier1873-6351
dc.identifierhttp://hdl.handle.net/11449/74660
dc.identifier10.1016/j.fct.2012.11.029
dc.identifierWOS:000322924700022
dc.identifier2-s2.0-84871743450
dc.identifier2-s2.0-84871743450.pdf
dc.identifier7501930236496670
dc.identifier4702004904231248
dc.identifier1768025290373669
dc.identifier0000-0002-1516-7765
dc.identifier0000-0003-1740-7360
dc.description.abstractStudies have shown that Casearia sylvestris compounds protect DNA from damage both in vitro and in vivo. Complementarily, the aim of the present study was to assess the chemopreventive effect of casearin B (CASB) against DNA damage using the Ames test, the comet assay and the DCFDA antioxidant assay. The genotoxicity was assessed by the comet assay in HepG2 cells. CASB was genotoxic at concentrations higher than 0.30μM when incubated with the FPG (formamidopyrimidine-DNA glycosylase) enzyme. For the antigenotoxicity comet assay, CASB protected the DNA from damage caused by H2O2 in the HepG2 cell line in concentrations above 0.04μM with post-treatment, and above 0.08μM with pre-treatment. CASB was not mutagenic (Ames test) in TA 98 and TA 102. In the antimutagenicity assays, the compound was a strong inhibitor against aflatoxin B1 (AFB) in TA 98 (>88.8%), whereas it was moderate (42.7-59.4%) inhibitor against mytomicin C (MMC) in TA 102. Additionally, in the antioxidant assay using DCFDA, CASB reduced reactive oxygen species (ROS) generated by H2O2. In conclusion, CASB was genotoxic to HepG2 cells at high concentrations; was protective of DNA at low concentrations, as shown by the Ames test and comet assay; and was also antioxidant. © 2012 Elsevier Ltd.
dc.languageeng
dc.relationFood and Chemical Toxicology
dc.relation3.977
dc.relation1,144
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAmes test
dc.subjectAntioxidant
dc.subjectCasearia sylvestris
dc.subjectCasearin B
dc.subjectComet assay
dc.subjectDCFDA
dc.subjectcasearin b
dc.subjecthydrogen peroxide
dc.subjectplant extract
dc.subjectreactive oxygen metabolite
dc.subjectunclassified drug
dc.subjectantigenotoxicity
dc.subjectantioxidant activity
dc.subjectCasearia
dc.subjectcell viability
dc.subjectchemoprophylaxis
dc.subjectcomet assay
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectDNA damage
dc.subjectdrug activity
dc.subjectdrug efficacy
dc.subjectdrug mechanism
dc.subjectdrug structure
dc.subjectgenotoxicity
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC 50
dc.subjectmutation inhibition
dc.subjectAflatoxin B1
dc.subjectAntimutagenic Agents
dc.subjectAntioxidants
dc.subjectChemoprevention
dc.subjectComet Assay
dc.subjectDiterpenes
dc.subjectDiterpenes, Clerodane
dc.subjectDNA Damage
dc.subjectDNA-Formamidopyrimidine Glycosylase
dc.subjectDose-Response Relationship, Drug
dc.subjectHep G2 Cells
dc.subjectHumans
dc.subjectHydrogen Peroxide
dc.subjectMutagens
dc.subjectPlant Extracts
dc.subjectReactive Oxygen Species
dc.subjectSalicaceae
dc.titleAssessment of the chemopreventive effect of casearin B, a clerodane diterpene extracted from Casearia sylvestris (Salicaceae)
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución